MDS secures multiple myeloma deal
A deal has been finalised making MDS Pharma Services the preferred contract research organization (CRO) of the Multiple Myeloma Research Consortium (MMRC) in the US, with further opportunities in Europe to follow.
Archives for April 25, 2006
Datalase marks success with expansion
Materials science firm Datalase has announced it has expanded its UK facility, targeting the pharmaceutical industry by applying its colour change technology in secondary packaging and on-product tablet marking.
Lonza grows more self-reliant in China
Chemicals firm Lonza has vowed to spend $200m (€160m) over the next few years to expand in southern China, further limiting its dependence on external suppliers of intermediates and active pharmaceutical ingredients (APIs).
CEL-SCI joins with US Navy to sink Malaria
The US Navy has extended an existing deal with Austrian biotech company CEL-SCI to further investigate the company's novel drug compound, CEL-1000, that could offer 100 per cent protection against Malaria.
SRI International makes Quality acquisition
SRI International has bought Quality Clinical Labs (QCL) to bring a new drug analysis component to its pre-clinical R&D services business.
New asthma device moves closer to Europe
Bespak is now ramping up manufacturing of Chiesi Farmaceutici's new dry powder inhaler (DPI), in preparation for clinical trials of the device in patients with asthma and COPD (chronic obstructive pulmonary disease).
Thermo finds right blend
Thermo has unveiled a new blend measurement solution for the real-time analysis of pharmaceutical blending processes in solid dosage form manufacturing which can be easily moved from blender to blender and used on any size pharmaceutical blender bin,...
Chronic illnesses offer blockbuster opportunities
Chronic diseases account for 70 per cent of the healthcare budget in the UK alone. New drugs in unment chronic disease areas offer real blockbuster potential for companies willing to take on the challenge.